WHO ICTRP trial
An exploratory clinical study on the efficacy and safety of trilaciclib combined…
ChiCTR2400079623 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400079623 |
|---|---|
| Public title | An exploratory clinical study on the efficacy and safety of trilaciclib combined with platinum-containing chemotherapy for bone marrow protection in advanced NSCLC |
| Scientific title | An exploratory clinical study on the efficacy and safety of trilaciclib combined with platinum-containing chemotherapy for bone marrow protection in advanced NSCLC |
| Primary sponsor | Xinyang Central Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | NSCLC |
| Interventions | Single-arm:Patients with advanced NSCLC diagnosed by pathology were screened after signing informed consent, and eligible subjects were treated with trilaciclib before receiving platinum-containing double-drug chemotherapy, with a treatment… |
| Registration date | Jan 8, 2024 |
| Target size | Single-arm:22 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: